Literature DB >> 27518548

Clinical evaluation of microcystic macular edema in patients with glaucoma.

N Murata1,2, T Togano1, D Miyamoto1, S Ochiai1, T Fukuchi1.   

Abstract

PurposeTo investigate the prevalence of microcystic macular edema (MME) in patients with glaucoma and the relationship between glaucomatous visual field defects and MME.Patients and methodsWe analyzed 636 eyes of 341 glaucoma patients who underwent spectral domain optical coherence tomography (SD-OCT). MME was defined as vacuoles observed in the inner nuclear layer (INL) on SD-OCT. Quantitative assessment of MME area was performed using en-face imaging obtained swept-source OCT (SS-OCT) and Adobe Photoshop CS6 Extended software. These values were compared with the visual field results with the Humphrey field analyzer.ResultsMME was observed in 1.6% of eyes. The visual field mean deviation (MD), pattern standard deviation (PSD) and visual acuity was significantly worse (P= 0.023, P=0.037, and P=0.018, respectively) in eyes with MME. The average MME area was 2.38±1.43%. There was no significant correlation between visual field deficits and MME area.ConclusionsThe MME detection rate based on general inspection was 1.6%. MME in glaucomatous eyes were associated with worse MD, PSD, and visual acuity. Further research is needed to increase the number of cases to allow for more detailed analysis.

Entities:  

Mesh:

Year:  2016        PMID: 27518548      PMCID: PMC5108025          DOI: 10.1038/eye.2016.190

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  13 in total

1.  Microcystic macular oedema in multiple sclerosis is associated with disease severity.

Authors:  Jeffrey M Gelfand; Rachel Nolan; Daniel M Schwartz; Jennifer Graves; Ari J Green
Journal:  Brain       Date:  2012-04-25       Impact factor: 13.501

2.  The global impact of glaucoma.

Authors:  B Thylefors; A D Négrel
Journal:  Bull World Health Organ       Date:  1994       Impact factor: 9.408

3.  The clinical spectrum of microcystic macular edema.

Authors:  Marloes C Burggraaff; Jennifer Trieu; Willemien A E J de Vries-Knoppert; Lisanne Balk; Axel Petzold
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-02-18       Impact factor: 4.799

4.  Automatic segmentation of microcystic macular edema in OCT.

Authors:  Andrew Lang; Aaron Carass; Emily K Swingle; Omar Al-Louzi; Pavan Bhargava; Shiv Saidha; Howard S Ying; Peter A Calabresi; Jerry L Prince
Journal:  Biomed Opt Express       Date:  2014-12-15       Impact factor: 3.732

5.  Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration.

Authors:  Ari J Green; Stephen McQuaid; Stephen L Hauser; Ingrid V Allen; Roy Lyness
Journal:  Brain       Date:  2010-04-21       Impact factor: 13.501

6.  Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.

Authors:  Shiv Saidha; Elias S Sotirchos; Mohamed A Ibrahim; Ciprian M Crainiceanu; Jeffrey M Gelfand; Yasir J Sepah; John N Ratchford; Jiwon Oh; Michaela A Seigo; Scott D Newsome; Laura J Balcer; Elliot M Frohman; Ari J Green; Quan D Nguyen; Peter A Calabresi
Journal:  Lancet Neurol       Date:  2012-10-04       Impact factor: 44.182

7.  The number of people with glaucoma worldwide in 2010 and 2020.

Authors:  H A Quigley; A T Broman
Journal:  Br J Ophthalmol       Date:  2006-03       Impact factor: 4.638

8.  Retinal inner nuclear layer microcystic changes in optic nerve atrophy: a novel spectral-domain OCT finding.

Authors:  Benjamin Wolff; Chrysanthi Basdekidou; Vivien Vasseur; Martine Mauget-Faÿsse; José-Alain Sahel; Catherine Vignal
Journal:  Retina       Date:  2013 Nov-Dec       Impact factor: 4.256

9.  Microcystic macular edema: retrograde maculopathy caused by optic neuropathy.

Authors:  Mathias Abegg; Muriel Dysli; Sebastian Wolf; Jens Kowal; Pascal Dufour; Martin Zinkernagel
Journal:  Ophthalmology       Date:  2013-10-15       Impact factor: 12.079

10.  Microcystic Inner Nuclear Layer Changes and Retinal Nerve Fiber Layer Defects in Eyes with Glaucoma.

Authors:  Tomoko Hasegawa; Tadamichi Akagi; Munemitsu Yoshikawa; Kenji Suda; Hiroshi Yamada; Yugo Kimura; Hideo Nakanishi; Masahiro Miyake; Noriyuki Unoki; Hanako Ohashi Ikeda; Nagahisa Yoshimura
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

View more
  4 in total

1.  Long-term rearrangement of retinal structures in a novel mutation of X-linked retinoschisis.

Authors:  Stefano Piermarocchi; Stefania Miotto; Davide Colavito; Elda Del Giudice; Alberta Leon; Veronica Maritan; Rita Piermarocchi; Alma Patrizia Tormene
Journal:  Biomed Rep       Date:  2017-07-27

2.  Risk factors for microcystic macular oedema in glaucoma.

Authors:  Golnoush Mahmoudinezhad; Diana Salazar; Esteban Morales; Peter Tran; Janet Lee; Jean-Pierre Hubschman; Kouros Nouri-Mahdavi; Joseph Caprioli
Journal:  Br J Ophthalmol       Date:  2021-11-05       Impact factor: 5.908

Review 3.  Macular imaging with optical coherence tomography in glaucoma.

Authors:  Vahid Mohammadzadeh; Nima Fatehi; Adeleh Yarmohammadi; Ji Woong Lee; Farideh Sharifipour; Ramin Daneshvar; Joseph Caprioli; Kouros Nouri-Mahdavi
Journal:  Surv Ophthalmol       Date:  2020-03-19       Impact factor: 6.048

Review 4.  Detection of Glaucoma Deterioration in the Macular Region with Optical Coherence Tomography: Challenges and Solutions.

Authors:  Kouros Nouri-Mahdavi; Robert E Weiss
Journal:  Am J Ophthalmol       Date:  2020-09-18       Impact factor: 5.258

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.